Image
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases.
This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life.
Welcome to the 13th Aging Research and Drug Discovery Meeting.
SPEAKERS ARDD 2026
Leaders in the aging and longevity field will describe the latest progress in the molecular, cellular and organismal basis of aging and our search for interventions.
    More speakers to be announced
    SPEAKERS ARDD 2025
    Speakers
    Michael Levitt
    Michael Levitt
    Stanford University, USA
    Morten Meldal
    Morten Meldal
    University of Copenhagen, Denmark
    Aisyah Sjöholm
    Aisyah Sjöholm
    Insilico Medicine, USA
    Ala Trusina
    Ala Trusina
    University of Copenhagen, Denmark
    Alejandro Aguilera Castrejon
    Alejandro Aguilera Castrejon
    Howard Hughes Medical Institute Janelia Research Campus, USA
    Alessandra Zonari
    Alessandra Zonari
    OneSkin
    Alex Zhavoronkov
    Alex Zhavoronkov
    Insilico Medicine, USA
    Alexey Terskikh
    Alexey Terskikh
    Harry Perkins Institute & University of Western Australia, Australia
    Amy Morgan
    Amy Morgan
    The University of Salford, UK
    Ana Maria Cuervo
    Ana Maria Cuervo
    Albert Einstein College of Medicine, US
    Anastasia Georgievskaya
    Anastasia Georgievskaya
    Haut.AI, Estonia
    Andrea Maier
    Andrea Maier
    National University of Singapore, Singapore
    Andrea Heinz
    Andrea Heinz
    University of Copenhagen
    Andreas Beyer
    Andreas Beyer
    Institute for Genetics, Faculty of Medicine, University of Cologne, Germany
    Andrei Seluanov
    Andrei Seluanov
    University of Rochester, US
    Andrew Adams
    Andrew Adams
    Eli Lilly and Company, USA
    Andy Poyi Tsai
    Andy Poyi Tsai
    Stanford University, USA
    Anna Murray
    Anna Murray
    University of Exeter, England
    Anne Brunet
    Anne Brunet
    Stanford University, USA
    Anne Marije van Harten
    Anne Marije van Harten
    Apollo Health Ventures, Luxembourg
    Anthony Atala
    Anthony Atala
    Wake Forest Institute for Regenerative Medicine, USA
    Avi Spier
    Avi Spier
    Novartis, Switzerland
    Axel Kowald
    Axel Kowald
    Institute for Biostatistics & Informatics in Medicine and Ageing Research
    Bartlomiej Piechowski-Jozwiak
    Bartlomiej Piechowski-Jozwiak
    Institute for Healthier Living Abu Dhabi, United Arab Emirates
    Ben Shenhar
    Ben Shenhar
    Weizmann Institute of Science
    Benjamin Johnson
    Benjamin Johnson
    Nature Health, UK
    Benjamin Friedrich
    Benjamin Friedrich
    Technische Universität Dresden, Germany
    Bente Klarlund
    Bente Klarlund
    University of Copenhagen, Denmark
    Berthil Clasen
    Berthil Clasen
    Eli Lilly and Company, USA
    Björn Schumacher
    Björn Schumacher
    University of Cologne, Germany
    Brian Kennedy
    Brian Kennedy
    National University of Singapore, Singapore
    Charlotte Suetta
    Charlotte Suetta
    University of Copenhagen, Denmark
    Christiane Volbracht
    Christiane Volbracht
    Lundbeck
    Christoph Kuppe
    Christoph Kuppe
    Aachen University, Germany
    Chuen Yan Leung
    Chuen Yan Leung
    Value Partners Group, Hong Kong
    Clive Cookson
    Clive Cookson
    Financial Times, UK
    Collin Ewald
    Collin Ewald
    Novartis Biomedical Research Diseases of Aging and Regenerative Medicine, Switzerland
    Cristiana Banila
    Cristiana Banila
    Mitra Bio, UK
    Daniela Bakula
    Daniela Bakula
    University of Copenhagen, Denmark
    Dario Valenzano
    Dario Valenzano
    Leibniz Institute on Aging, Germany
    David Dodick
    David Dodick
    Mayo Clinic, USA
    David Dreyer Lassen
    David Dreyer Lassen
    University of Copenhagen, Denmark
    David Helmut Meyer
    David Helmut Meyer
    University of Cologne
    Denis Villemonais
    Denis Villemonais
    University of Strasbourg, France
    Denis Sarigiannis
    Denis Sarigiannis
    National Hellenic Research Foundation
    Dominik Duscher
    Dominik Duscher
    MuseCell Innovations, Singapore
    Dudley Lamming
    Dudley Lamming
    University of Wisconsin-Madison, USA
    Edward Rudnic
    Edward Rudnic
    Maxwell Biosciences, USA
    Elena Sergeeva
    Elena Sergeeva
    Tufts University, USA
    Elena Bonfiglioli
    Elena Bonfiglioli
    Pharma and Life Sciences Microsoft
    Elias Bou Samra
    Elias Bou Samra
    L'Oréal Research & Innovation, France
    Elise Cachat
    Elise Cachat
    University of Edinburgh, Scotland
    Emma Teeling
    Emma Teeling
    University College Dublin, Ireland
    Eric Verdin
    Eric Verdin
    Buck Institute for Research on Aging, USA
    Ethan Liu
    Ethan Liu
    Westlake University, China
    Evandro Fang
    Evandro Fang
    University of Oslo, Norway
    Evelyne Bischof
    Evelyne Bischof
    Sheba Longevity Center, Tel Hashomer
    Fabrizio d'Adda di Fagagna
    Fabrizio d'Adda di Fagagna
    IFOM; IGM-CNR, Italy
    Fedor Galkin
    Fedor Galkin
    Insilico Medicine, UAE
    Garegin Papoian
    Garegin Papoian
    Deep Origin, USA
    Gareth Shepherd
    Gareth Shepherd
    NHS and AFAR
    Garri Zmudze
    Garri Zmudze
    LongeVC, Switzerland
    Geoffrey West
    Geoffrey West
    Santa Fe Institute, USA
    Glen Pridham
    Glen Pridham
    Weizmann Institute of Science
    Heike A. Bischoff-Ferrari
    Heike A. Bischoff-Ferrari
    University of Basel, Switzerland
    Henri Jasper
    Henri Jasper
    Genentech / Roche, USA
    Hilde Loge Nilsen
    Hilde Loge Nilsen
    AgeLab.no, Norway
    In Hwa Jang
    In Hwa Jang
    University of Minnesota, USA
    Jackie Han
    Jackie Han
    Peking University, China
    Jacob Falck Hansen
    Jacob Falck Hansen
    Lundbeckfonden BioCapital, Denmark
    James Kirkland
    James Kirkland
    Robert and Arlene Kogod Center on Aging, USA
    Jamie Justice
    Jamie Justice
    XPRIZE Healthspan, USA
    Jan Hoeijmakers
    Jan Hoeijmakers
    University of Cologne, Germany
    Jan Gruber
    Jan Gruber
    National University of Singapore, Singapore
    Jaron Rabinovici
    Jaron Rabinovici
    Sheba Medical Center
    Javier Maria Peralta Ramos
    Javier Maria Peralta Ramos
    Weizmann Institute of Science, Israel
    Jean-Marc Lemaitre
    Jean-Marc Lemaitre
    Institute of Regenerative Medicine and Biotherapies of Montpellier, France
    Jeffrey West
    Jeffrey West
    H. Lee Moffitt Cancer Center & Research Institute, US
    Jeroen Aerssens
    Jeroen Aerssens
    Rejuvenate Biomed, Belgium
    Jerome Feige
    Jerome Feige
    Nestlé, Switzerland
    Joe Betts-LaCroix
    Joe Betts-LaCroix
    Retro Biosciences, USA
    John Newman
    John Newman
    Buck Institute, US
    Jonathan Gootenberg
    Jonathan Gootenberg
    Harvard Medical School, USA
    Juan Carlos Izpisua Belmonte
    Juan Carlos Izpisua Belmonte
    Altos Labs, USA
    Jun Wu
    Jun Wu
    University of Texas Southwestern Medical Center, USA
    Kazuto Kawamura
    Kazuto Kawamura
    Max Planck Institute for Biology of Ageing
    Kennedy  Schaal
    Kennedy Schaal
    Rejuve.Bio, US
    Kitsu Egerton
    Kitsu Egerton
    Baillie Gifford, UK
    Kristen Fortney
    Kristen Fortney
    BioAge Labs, USA
    Kotb Abdelmohsen
    Kotb Abdelmohsen
    National Institutes of Health, USA
    Kunlin Jin
    Kunlin Jin
    Aging and Disease
    Kyle Loh
    Kyle Loh
    Stanford University, USA
    Laura Niedernhofer
    Laura Niedernhofer
    University of Minnesota Medical School, USA
    Leo Lopez
    Leo Lopez
    Tufts University, USA
    Lida Katsimpardi
    Lida Katsimpardi
    Institute for Regenerative Medicine and Biotherapies, IRMB, France
    Lisa Melton
    Lisa Melton
    Nature Biotechnology, UK
    Lotte Bjerre Knudsen
    Lotte Bjerre Knudsen
    Novo Nordisk, Denmark
    Luc Aguilar
    Luc Aguilar
    L'Oréal Research & Innovation, France
    Lucas Camillo
    Lucas Camillo
    Shift Bioscience
    Lucia Marucci
    Lucia Marucci
    University of Bristol
    Luigi Ferrucci
    Luigi Ferrucci
    National Institute on Aging, USA
    Lykke Sylow
    Lykke Sylow
    University of Copenhagen, Denmark
    Mahdi Moqri
    Mahdi Moqri
    Harvard University, USA
    Marc Bernegger
    Marc Bernegger
    Maximon, Switzerland
    Marco Demaria
    Marco Demaria
    European Research Institute for the Biology of Ageing (ERIBA)
    Marija Cvijovic
    Marija Cvijovic
    University of Gothenburg and Chalmers University of Technology, Sweden
    Marissa Schafer
    Marissa Schafer
    Mayo Clinic, USA
    Marta Guasch-Ferré
    Marta Guasch-Ferré
    University of Copenhagen, Denmark
    Martin Borch Jensen
    Martin Borch Jensen
    Gordian Biotechnology
    Maximina Yun
    Maximina Yun
    Sheikh Zayed Genetic Research Centre,Wew, UAE
    Max Unfried
    Max Unfried
    National University of Singapore, Singapore
    Max Wilson
    Max Wilson
    University of California, Santa Barbara, USA
    Michael Ringel
    Michael Ringel
    Life Biosciences, USA
    Michael Antonov
    Michael Antonov
    Deep Origin, USA
    Michela Deleidi
    Michela Deleidi
    Institut Imagine, France
    Miriam Merad
    Miriam Merad
    Mount Sinai School of Medicine in New York, USA
    Mirre Simons
    Mirre Simons
    University of Sheffield
    Morten Scheibye-Knudsen
    Morten Scheibye-Knudsen
    University of Copenhagen, Denmark
    Mourad Topors
    Mourad Topors
    Repair Biotechnologies, USA
    Murali Venkatesan
    Murali Venkatesan
    Danaher Corporation, USA
    Nan Hao
    Nan Hao
    University of California San Diego,
    Nathan LeBrasseur
    Nathan LeBrasseur
    Mayo Clinic, USA
    Naveh Raz
    Naveh Raz
    Weizmann Institute of Science
    Neda Bagheri
    Neda Bagheri
    University of Washington, USA
    Niklas Anzinger
    Niklas Anzinger
    Infinita City, Honduras
    Nir Barzilai
    Nir Barzilai
    Albert Einstein College of Medicine, USA
    Omar Abudayyeh
    Omar Abudayyeh
    Harvard Medical School, USA
    Paul Kohlhaas
    Paul Kohlhaas
    Molecule, Switzerland
    Peter Mullen
    Peter Mullen
    University of Southern California, USA
    Peter Fedichev
    Peter Fedichev
    Gero, Singapore
    Peter Lidsky
    Peter Lidsky
    City University of Hong Kong, Hong Kong
    Philipp Gut
    Philipp Gut
    Nestlé, Switzerland
    Priya Singhal
    Priya Singhal
    Biogen, USA
    Rafael de Cabo
    Rafael de Cabo
    National Institute on Aging, USA
    Riekelt Houtkooper
    Riekelt Houtkooper
    University of Amsterdam, Netherlands
    Risa Starr
    Risa Starr
    Academy for Health and Lifespan Research
    Rusty Montgomery
    Rusty Montgomery
    BioAge Labs, USA
    Ryan Smith
    Ryan Smith
    TruDiagnostic, USA
    Sam Burrows
    Sam Burrows
    NHS Frimley ICB, UK
    Sara Hägg
    Sara Hägg
    Karolinska Institutet
    Sara Bonnes
    Sara Bonnes
    Mayo Clinic
    Sebastian Lobentanzer
    Sebastian Lobentanzer
    Helmholtz Center
    Sebastien Thuault
    Sebastien Thuault
    Nature Aging, US
    Sergey Jakimov
    Sergey Jakimov
    LongeVC, Switzerland
    Shahaf Peleg
    Shahaf Peleg
    FBN Dummerstorf, Germany
    Sharon Rosenzweig-Lipson
    Sharon Rosenzweig-Lipson
    Life Biosciences, USA
    Sophia Liu
    Sophia Liu
    Ragon Institute of MGB, MIT, and Harvard, USA
    Steffen Rulands
    Steffen Rulands
    Ludwig-Maximilians-Universität München, Germany
    Steve Horvath
    Steve Horvath
    Altos Labs, USA
    Steve Austad
    Steve Austad
    University of Alabama Birmingham, USA
    Thomas Rando
    Thomas Rando
    University of California Los Angeles, USA
    Tina Woods
    Tina Woods
    Exposome Moonshot
    Tom Zuber
    Tom Zuber
    Zuber Lawler, USA
    Tomás Schmauck-Medina
    Tomás Schmauck-Medina
    University of Oslo
    Tomaz Rozmaric
    Tomaz Rozmaric
    Ludwig Boltzmann Institute for Traumatology in Vienna
    Tony Wyss-Coray
    Tony Wyss-Coray
    Stanford University, USA
    Tuomas Tammela
    Tuomas Tammela
    Memorial Sloan Kettering Cancer Center, US
    Tzipora Strauss
    Tzipora Strauss
    Longevity Center at Sheba Medical Center
    Uri Alon
    Uri Alon
    Weizmann Institute of Science
    Vadim Gladyshev
    Vadim Gladyshev
    Harvard Medical School, USA
    Vera Gorbunova
    Vera Gorbunova
    University of Rochester, US
    Vijay Vaswani
    Vijay Vaswani
    Omniscope, USA
    Wanviput Sanphasitvong
    Wanviput Sanphasitvong
    Virallife Scientific Wellness Center/ Bumrungrad International
    Wei-Wu He
    Wei-Wu He
    Human Longevity Inc.
    Weilan Wang
    Weilan Wang
    National University of Singapore,Singapore
    Wenting Zhao
    Wenting Zhao
    Nanyang Technological University, Singapore
    William Harborne
    William Harborne
    LongGame, United Kingdom
    XingLi Wang
    XingLi Wang
    Fosun Pharma, China
    Yousin Suh
    Yousin Suh
    Columbia University, USA
    Yujiiang Shi
    Yujiiang Shi
    Fudan University, China
    Yusuf Roohani
    Yusuf Roohani
    Arc Institute, USA
    Yuta Lee
    Yuta Lee
    Accelerated Biosciences, USA
    Zane Koch
    Zane Koch
    University of California San Diego
    Todd White
    Todd White
    The Thalion Initiative, USA
    Andrea Olsen
    Andrea Olsen
    California Institute of Technology, USA
    Sierra Lore
    Sierra Lore
    Buck Institute for Research on Aging, USA
    Dominika Wilczok
    Dominika Wilczok
    Duke University
    Charlotte Owen-Woods
    Charlotte Owen-Woods
    Cell
    Lars Hartenstein
    Lars Hartenstein
    McKinsey Health Institute
    Andrea Cipriano
    Andrea Cipriano
    Stanford
    Aleksandr Tyshkovskiy
    Aleksandr Tyshkovskii
    Harvard Medical School
    Daisy Cai
    Daisy Cai
    B Capital
    Vanessa Sinatti
    Vanessa Sinatti
    Aptah Bio
    Bohan Zhang
    Bohan Zhang
    Harvard Medical School

    ARDD Sponsors 2025

    Sponsorship Enquiry:
    Morten Scheibye-Knudsen | [email protected]
    Tier 1 Sponsors
    Image
    Image
    Image
    Image
    Image
    Image
    Tier 2 Sponsors
    Image
    Image
    Image
    Image
    Tier 3 Sponsors
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Tier 4 Sponsors
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Tier 5 Sponsors
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Knowledge & Education Partners

    Image
    ARDD Knowledge Partner
    Image
    ARDD Education Partner
    Image
    ARDD Education Partner
    Image
    ARDD Education Partner

    Media Partners

    Image
    Image
    Image
    Image
    Nature Health
    Image
    Image
    Watch the presentations from the largest aging research
    and drug discovery meeting free at your own pace
    CHAIRS
    "We are really looking forward to this year's ARDD meeting. We are extremely humbled, honored and excited that so many amazing speakers will join our meeting that will be onsite at the University of Copenhagen. This year we maintain our focus on young scientists who will be the future of our field and we have a large amount of speaker slots for these rising stars. In addition, the highly succesful Longevity Medicine workshop will be repeated and we are in the process of organizing further exciting workshops. More to come!"
    Morten Scheibye-Knudsen
    The University of Copenhagen
    • Morten Scheibye-Knudsen
      The University of Copenhagen
    • Daniela Bakula
      The University of Copenhagen
    • Alex Zhavoronkov
      Insilico Medicine
    People
    • Morten
      Scheibye-Knudsen
      with the ARDD team since 2016
    • Daniela Janina
      Bakula
      with the ARDD team since 2019
    • Alex
      Zhavoronkov
      with the ARDD team since 2014
    • Evelyne Yehudit
      Bischof
      with the ARDD team since 2021
    • Max
      Unfried
      with the ARDD team since 2022
    • Stephanie
      Tsang
      with the ARDD team since 2022
    Recommended Reading
    Subscribe to our news!
    ARDD Quotes
    • Really enjoyed the breadth of talks and discussions.
      Michael Levitt
      Nobel Prize in Chemistry 2013
      Stanford
    • Phenomenal conference in the Rejuvenation Field.
      Steve Horvath
      Principal Investigator
      Altos Lab
    • Where one can learn about aging scientifically, clinically and in real life.
      Xingli Wang
      Fosun Global Partner
      Fosun Pharma
    • The ARDD event pioneers the future of healthy aging, driving breakthroughs in longevity research while opening a new era of cosmetic innovation
      Luc Aguilar
      Chief Scientific Officer
      L’ORÉAL R&I
    • The Aging Research and Drug Discovery Meeting was a great opportunity to see where the world is in terms of cutting edge research focused on the biology of aging and mechanisms that could help treat or prevent age-related disorders. It’s perhaps the preeminent meeting of this kind.
      David Glass
      Vice President, Research
      Regeneron
    • The ARDD 2024 conference was the ultimate go to meeting for ageing research, covering a broad range of topics from genetics, genomics, proteomics, basic molecular and biological mechanism to interesting validation of concepts in cellular systems and animal systems. The question underpinning the conference is gigantic and existential for mankind; how to prolong lifespan with maintained quality of life.
      As the head of R&D for Lundbeck, a pharmaceutical company focusing on diseases of the nervous systems, I find it challenging, still very intriguing and highly interesting to engage in the scientific community on the very topic of aging with maintained brain health. I am therefore very much looking forward to the 2025 ARDD conference, as another opportunity to build scientific networks and learn about the most recent research on longevity.
      Johan Luthman
      Executive Vice President, R&D
      Lundbeck
    • The ARDD conference has become the premier meeting in Europe to learn the latest advances in the biology of aging and development of medicines to delay it
      David Sinclair
      Harvard Medical School

    This was a great event which brought together academics and industry to find out about the latest developments the field of ageing.

    Amy Morgan

    University of Salford

    It was an excellent meeting!

    Peter Lidsky

    City University of Hong Kong

    The finest aging meeting there is for bringing diverse stakeholders together.

    Steve Austad

    University of Alabama at Birmingham

    best aging meeting of the circuit

    fabrizio d'adda di fagagna

    IFOM & CNR

    Just great

    Max

    Gero

    Everything was perfectly arranged.

    Xiaodong Liu

    Westlake university

    Without doubt this conference is the BEST in ageing and longevity research!

    Christoph Kuppe

    RWTH Aachen University

    Probably the best week of the year for me...

    Pierre Jacob

    Heidelberg University

    ARDD was a unique mix of industry and academia where the cutting edge aging researchers were able to exchange ideas with biotech and pharma luminaries working on translation of these discoveries.

    Max Wilson

    University of California Santa Barbara

    By combining practitioners with basic research, particularly with physics in aging this was both a unique and a very stimulating meeting which I very much enjoyed.

    Geoffrey West

    Santa Fe Institute

    Ageing insights

    Trevor Archer

    Longevience

    It has been my first ARDD - but for sure not my last. - Great organisation!!!!

    Michael Schaeffler

    Cfm Oskar Tropitzsch GmbH

    The biggest event not just in aging research, but perhaps, in biomedical science in general

    Fedor Galkin

    Insilico Medicine

    Fantastic conference - the meeting is a window showcasing the state-of-the art of aging research. It is THE annual event that brings the people in the field together, but also brings new people into the field.

    Shahaf Peleg

    FBN Dummerstorf

    What I loved about ARDD 2025? Brilliant science, thought-provoking panels, and the kind of networking that turns colleagues into collaborators (and occasionally into late-night debate partners). A truly inspiring meeting -- thanks to the organizers!

    Marco Demaria

    European REsearch Institute for the Biology of Ageing (ERIBA)

    Very good service and a many interesting lectures

    Tomas Lenz

    Longevience AB

    ARDD had great speakers, great atmosphere and awesome vibes. I learned a lot, connected and just had fun.

    Naveh Raz

    Weizmann Institute of Science

    Dynamic interactions among academics, clinicians, and industry professionals. Lots of stimulating discussion. Really enjoyable!

    Wenting ZHAO

    Nanyang Technological University

    I truly appreciate being a part of ARDD 2025 and meeting world leaders in the field of healthy longevity

    Bartlomiej Piechowski-Jozwiak

    Institute for Healthier Living Abu Dhabi

    Unique opportunity for industry and academic research to come together

    Anonymous

    ARDD has become the premier event in longevity pharmacology, drawing hundreds of participants with tremendous enthusiasm and energy.

    Joao Pedro Magalhaes

    University of Birmingham

    To advance anti-aging and rejuvenation technology, we need to focus on reality, as Nature and time can't be fooled.

    Lingyan Shi

    University of California, San Diego

    The science is phenomenal and represents state-of-the-art research in healthspan extending research globally from academic and industry leaders. There is a magical, collaborative atmosphere.

    Laura Niedernhofer

    UMN

    ARDD 2025 delivered a unique rigorous and forward-looking program. It is an excellent meeting to challenge ideas and initiate new collaborations

    LEMAITRE

    INSERM

    Outstanding event which delivers a huge volume of educational content on the state of the art in aging and drug discovery research. ARDD offers great opportunities to network with established leaders and rising stars in the field over meals and beverages, which were all generously provided for. Returning for the second year, seeing familiar faces, and making lasting connections was a pleasure and I am very glad to have participated once again. I highly recommend this event for medical researchers, entrepreneurs, or enthusiasts alike.

    Thomas Guttenberger

    Metacoder AI

    The ARDD conference was exceptionally well organized, with a thoughtfully curated program that brought together cutting-edge topics at the intersection of aging research, drug discovery, and AI. It was inspiring to see how the event set an example for how industry and academia can engage productively, bridging perspectives to drive innovation forward. ARDD truly demonstrated how conferences can not only share knowledge but also shape the future of the field.

    Marija Cvijovic

    Mathematical Sciences, University of Gothenburg

    ARDD is an invaluable meeting that bridges basic science with clinical translation, making it a leading forum for advancing aging research and drug discovery. It’s an incredible opportunity to engage with a global community of scientists and industry leaders who share the goal of extending healthspan by targeting the biology of aging. I was proud to present Life Biosciences’ progress in cellular rejuvenation, and as an ARDD sponsor, we were able to highlight our pioneering work while fostering relationships that will help move the entire field forward.

    Sharon Rosenzweig-Lipson

    Life Biosciences

    I am VERY impressed with the quality of people and diverse range of ARDD attendees: academics, companies, medical doctors, investors, longevity enthusiasts, research scientists, thought leaders. Everyone attending was fully invested in absorbing the event content, having fun and forming lasting connections. This was by far the most engaged conference audience I've come across. Being surrounded by the energy of so many brilliant minds all invested in creating lasting change in the world for five days and nights provides a unique bonding experience. I am excited to see what the future holds as this amazing community works together to create long-term health & wellness globally!

    Sarah Aubrey

    Maxwell Biosciences

    The conference featured an outstanding lineup of speakers, each offering novel insights and innovative perspectives into the field of aging research. The audience was highly engaged, representing a diverse range of research fields, which provided an excellent networking opportunity. Taken together, ARDD offers a unique chance to connect, share ideas, and stay at the forefront of current aging research. I look forward to the next ARDD.

    Andrea Heinz

    Department of Pharmacy, University of Copenhagen

    ARDD 2024 was one of the most exciting meetings I have ever been to. It brought together great scientists from academia, biotech, and pharma, it promoted positive interactions for funding opportunities and startups,and created a great forum for brainstorming and hearing about transformative technologies in the workshops. And Alex’s proposal to Dominika most memorable!

    Adam Antebi

    Max Planck Institute for BIology of Ageing, Cologne, Germany

    We are at a pivotal moment. The stars have aligned to make real progress in understanding aging and ultimately extending longevity. I found ARDD to be the nexus where diverse perspectives converge, accelerating this progress.

    Albert-László Barabási

    Northeastern University

    Attending for the first time, I found the ARDD conference to be a remarkable forum for exchanging groundbreaking ideas and accelerating the science of healthy longevity. The collective commitment to pushing the boundaries of research and making a lasting impact is truly inspiring

    Alireza Haghighi

    Harvard Medical School

    The ARDD is THE state-of-the-art event for entrepreneurs, scientists, clinicians and investors to shape the future of health optimization. It is not only scientifically stimulating, but also the most important meeting to build social interconnections within our field.

    Andrea Maier

    National University of Singapore

    ARDD2024 has been a very inspiring, high-quality scientific event

    Andreas Beyer

    University of Cologne

    ARDD was a wonderful conference that highlighted many recent advances in aging research. It was also great to see aging research translating into potentially life-saving and life-extending treatments for many age-related illnesses

    Anthony Schwartz

    VitaDao

    ARDD has a very particular vibe. It manages to be a hardcore longevity conference and at the same time, a lot of fun. Here, it’s easy to catch up with the latest research and breakthroughs in the field, have some quality time with old friends, and make new ones. For me as a journalist, ARDD is also a major source of stories that packs my interview schedule for months ahead.

    Arkadi Mazin

    Staff writer at Lifespan.io

    The ARDD2024 once again showcased the thrives that the field of the biology of aging has been making from discovery science to medical translation. For the first time we can now target the mechanisms of aging such as genome instability, which drives aging at the very root cause, while at the same time we can now quantify biological age thus enabling clinical testing of geroprotective interventions

    Björn Schumacher

    University of Cologne

    Once again, ARDD has proven to be the best longevity conference of the year - diverse attendees with varied expertise, exciting talks and a perfect atmosphere. I am already looking forward to next year to see what they think of next.

    Brian Kennedy

    National University of Singapore

    As a first time attendee, the diversity of excellent research, and the ability to interact with companies or investors or the scientists performing work at the bench, that could be found at ARDD, provided a unique opportunity for me. I have never encountered this breadth of individuals at a conference. It was a wealth of new data, and included good conversation about my own research. I am already in conversation about experiments with international colleagues that I couldn't have met without attending ARDD.

    Christina Camell

    University of Minnesota

    ARDD is the "must go" conference for aging science and longevity. It brings together world-renowned experts in the field of aging, as well as longevity investors and practitioners. The venue is outstanding, and the activities planned by the organizers are super fun!

    David Furman

    Buck Institute

    As an inventor, it was wonderful to learn about many open challenges in the fields of aging and longevity, for which we could build new tools. Great technologies should be driven by great questions and problems, and aging and longevity tie to many of the core questions and problems at the heart of diseases, human suffering, and human well-being.

    Ed Boyden

    MIT

    ARDD continues to impress me with its interdisciplinary approach, bringing together cutting-edge research from across fields. This year was particularly remarkable, with scientists from diverse disciplines, such as bioengineering (organs-on-chips/ organoid fields), AI life models, and genetic medicine, all contributing invaluable insights. The synergy at the intersection of these fields was inspiring and essential for advancing our understanding of ageing and future longevity developments. I am honoured to be part of such a transformative event.

    Emad Moeendarbary

    University College London

    ARDD2024 is probably one the best organized events I have ever attended. It was great to meet so many top anti-aging researchers in person, some of whom originally inspired me to start working in this field

    Fedor Galkin

    Insilico Medicine

    Presenting at the conference this year was a profound reminder of the power of collaboration and innovation. The exchange of ideas between Academy and Industry ignited a collective enthusiasm in the ageing field that will undoubtedly drive our future endeavors. It's inspiring to see how we can transform challenges into opportunities when the two worlds collide.

    Filipe Cabreiro

    University of Cologne

    By a wide margin, the ARDD is the perfect place to meet both scientists and entrepreneurs who want to foster longevity science. So if you want long and healthy lives, ARDD is the conference to attend.

    Georg Fuellen

    Universität Rostock

    ARDD is the premier conference for anyone seeking the latest updates in aging research, science, and technology. I’ve attended for the past three years and plan to return next year. The event has helped me build valuable connections and friendships, as well as generate numerous leads. I highly recommend it to anyone in the field!

    Gil Blander

    InsideTrackers

    I greatly enjoyed ARDD2024! This was certainly the best Geroscience meeting I ever attended. I liked especially the combination of basic science and applied research, the latter often by start-up companies. One major effect of ARDD is that many basic scientists now begin to take an active interest in translating and commercializing their own research. It is this what makes Geroscience blossom into a future of improved health span

    Jan Vijg

    Albert Einstein College of Medicine

    ARDD is one of the most important and exciting conferences in the aging field. The combination of speakers and attendees from across academic, pharma, biotech, and other sectors that the organizers achieved is truly unique, and the programs have been consistently excellent since I began attending. Notable features of the 2024 conference were the expanded representation by pharma and the dedicated sessions on XPRIZE healthspan, physics in aging, and longevity medicine. I am already looking forward with excitement to see what ARDD has in store for 2025.

    Jesse Potanik

    Harvard Medical School

    This is a great event to find out about some of the early breakthroughs in aging research without the marketing spin and hype. I appreciated the mix of researchers from different countries as well as the reality check from pharma companies on how hard it is to bring aging drug discoveries to people. I would recommend having a media event that helps summarize some of the key discoveries or themes for a wider audience.

    Jessica Davis Plüss

    Journalist at SWI swissinfo.ch

    The ARDD conference is a unique high-level scientific meeting in aging research that facilitates discussions with the world’s leading experts in the field. Both at the preclinical level and for clinical trials, academics and start-ups present their work and outline new directions for the sector. In its latest edition in 2024, the organizers included workshops where researchers and company representatives discussed their methods and results in detail in a friendly atmosphere, similar to a lab meeting with team members. Everything takes place in beautiful Copenhagen, which is a plus!

    Mar de Miguel

    Staff writer at BioWorld

    The 11th ARDD meeting brought together the best of academia, industry, and innovative discourse under one roof, with the goal of advancing healthy aging for all. I am grateful for the organisers’ commitment to creating an inclusive platform, where researchers and entrepreneurs of all career stages can present diverse views on leading developments in the aging field

    Matthew Key

    University of Southern Denmark

    ARDD is a wonderful conference because it brings together researchers, clinicians, industry leaders, investors, and even big pharma to discuss longevity and aging against the beautiful backdrop of Copenhagen! We loved absorbing cutting edge science, catching up with colleagues, and establishing novel collaborations with new friends!

    Max Shokhirev

    Tally Health

    ARDD is a premiere event in what is going to be the most important space for biomedical research in the future—how to extend healthspan and lifespan for everyone. It brings together a spectacular set of basic researchers, biotech entrepreneurs, investors, and large pharmaceutical company representatives to develop solutions and build connections for how we advance this cause

    Michael Ringel

    BCG

    The ARDD2024 was a fantastic event bringing the worlds leading researchers in the aging field together to a konference on the highest international level. As an invited speaker in the session 'Physics in Aging Biology' I experienced presentations with very high quality which put the scale for physical modelling on the highest level. The konference as a whole was excellently organized on the beautiful premises of Copenhagen University

    Mogens Høgh Jensen

    University of Copenhagen

    The ARDD2024 conference was a fantastic opportunity to witness groundbreaking aging research and the translation of ideas into action, with participation from leading pharma, biotech, and academic experts. The event was brilliantly organized, not just for absorbing insights from top minds in the field but also for meaningful conversations and networking. I went home refreshed and buzzing with excitement about the future of aging research.

    Naisha Shah

    BioAge

    If I could describe my experience in one word, it would be connection. Witnessing the commencement of a shift towards a new clinical specialty called "healthy longevity medicine", we can see how applying systems thinking in biology and in technology can bring the latest evidence can be linked to actionable insights today. From the interrelation between AI technology and medicine to in-depth discussions on geroscience and senolytics, it is these connections that will allow us to achieve the future of healthy longevity medicine.

    Nicole Sirotin

    Institute for Healthier Living Abu Dhabi

    The energy in this meeting was incredible. It was especially nice to see the engagement from interdisciplinary scientists, as success in this field will clearly require experimental, technological, and conceptual breakthroughs

    Omer Karin

    Imperial College London

    In the field of Aging and Longevity, most conferences tend to be either overly theoretical or heavily focused on business. ARDD stands out as one of the few meetings that strikes the ideal balance between academic translation and industrial scientific rigor. And this is why as a scientist and as an investor I thoroughly enjoy ARDD because it brings together the most diverse and distinguished group of leaders to discuss, deliberate and drive the field of aging and longevity forward

    Reghav Seghal

    Healthy Longevity Clinic

    ARDD continues to be one of the most enriching and scientifically exhilarating conferences in the healthspan community. It attracts some of the best academic and start-up talent in the world and is a beacon to understanding the advancements taking place in the longevity community

    Robin Mansukhani

    Deciduous Therapeutics

    The ARDD conference keeps developing for each year and the ARDD2024 version was a great experience with the addition of different parallel sessions. I also enjoyed meeting so many friends and colleagues from around the world and the networking opportunities are endless. From now on, it is one of the essential yearly conferences for me!

    Sara Hääg

    Karolinska Institute

    Not only does ARDD feature some cutting-edge research but it's also a great opportunity to meet and connect with various stakeholders, including newcomers, and sample views and opinions from different corners of the field. ARDD has a really positive vibe and I always end that last week of August in the beautiful city of Copenhagen feeling energized in spite of the long sessions and the intensity of the meeting! ARDD is one of those events in the aging and longevity space that you don't want to miss.

    Sebastien Thuault

    Chief Editor of Nature Aging

    I will never forget the ARDD conference in Copenhagen in August 2024. The phenomenal talks by leading scientists on promising rejuvenating interventions made me very hopeful for the future.

    Steve Horvath

    Altos Lab

    I attended ARDD2024 for the first time because I was invited to give a talk. As a synthetic biologist who entered the field of aging research in 2024, I learned tremendously from the presentations and discussions. Life is short, and longevity research is long, so why don't we start it now by learning from and attending ARDD2025?

    Tae Seok Moon

    Professor at J. Craig Venter Institute

    ARDD has just become a go-to meeting in the aging and longevity space. No other meeting brings together such a diverse array of experts, ranging from academic research, the investment community, and the start-up/biotechnology world.

    Thomas Rando

    Stanford University

    It will be a pleasure for me to say that ARDD is by far the most educative academic and serious conference in the world of longevity and I hope more to come.

    Tzipi Strauss

    Sheba Medical Center

    The Physics of Aging session was the first of its kind – truly revolutionary

    Uri Alon

    Weizmann Institute of Science

    ARDD is my favorite conference! The quality of the science was top notch, topics were exciting, and the atmosphere was inspiring and energizing.

    Vera Gorbunova

    University of Rochester

    ARDD is one of the most remarkable conferences in the field. It brings together several reputable KOLs giving a deep and broad perspective of where the science is and soon will be and the clinical implementations of such discoveries. ARDD is a think tank and a must for those who want to make a tangible difference in healthy aging research

    Vittorio Sebastino

    Turn.bio

    What I love about ARDD is the breadth of strategies, depth of scientific knowledge, and the consistency of supportive and collaborative people that attend this meeting. No matter what strategies you believe in, for this one week in Copenhagen, we are united in spirit to strive for healthspan and lifespan. It is a truly inspiring event.

    Yuta Lee

    Accelerated Biosciences

    ARDD was an exceptional event, uniting leaders from science, business, investment, and healthcare to accelerate progress toward living better, longer.

    Zoe Du

    Buck Institute

    It was my first ARDD event and I've immediately become a fan of this yearly series! It was very unlike a typical conference, Instead, it was like a scientific and business club of the highest caliber. People shared cutting edge research, ideas, networked and conducted business, but also had a lot of fun in such a natural way and so relevantly, it felt like the whole event was designed to be a thematic party.
    But the true value was the level of insight. The organizers managed to strike a rare balance between strategic or even educational presentations, and deeply technical ones, sharing cutting edge advances in science and tech. You can judge the quality of the event when you attend the last lecture of the day at 20.30 and the hall is literally packed...Not a typical thing at a conference"

    Andrii Buvailo

    Co-founder & publisher BioPharmaTrend.com